N-ACETYLATION PHENOTYPING WITH DAPSONE IN A MAINLAND CHINESE POPULATION

被引：30

作者：

HORAI, Y

ZHOU, HH

ZHANG, LM

ISHIZAKI, T

机构：

[1] NATL MED CTR,CLIN RES INST,DIV CLIN PHARMACOL,TOYAMA 1-21-2,SHINJUKU KU,TOKYO 162,JAPAN

[2] HUNAN MED COLL,NATL TRAINING CTR CLIN PHARMACOL,HUNAN,PEOPLES R CHINA

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1988年 / 25卷 / 01期

关键词：

D O I：

10.1111/j.1365-2125.1988.tb03285.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：81 / 87

页数：7

相关论文

共 26 条

[1] PLASMA AND SALIVARY PHARMACOKINETICS OF DAPSONE ESTIMATED BY A THIN-LAYER CHROMATOGRAPHIC METHOD
AHMAD, RA
ROGERS, HJ
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (02) : 129 - 133
[2] CARR K, 1978, BRIT J CLIN PHARMACO, V6, P421, DOI 10.1111/j.1365-2125.1978.tb04606.x
[3] GENETICALLY-DETERMINED VARIABILITY IN ACETYLATION AND OXIDATION - THERAPEUTIC IMPLICATIONS
CLARK, DWJ
[J]. DRUGS, 1985, 29 (04) : 342 - 375
[4] DENGLER HJ, 1984, EUR J CLIN PHARM, V27, P253
[5] DRAYER DE, 1977, CLIN PHARMACOL THER, V22, P251
[6] ACETYLATOR PHENOTYPING OF TUBERCULOSIS PATIENTS USING MATRIX ISONIAZID OR SULFADIMIDINE AND ITS PROGNOSTIC SIGNIFICANCE FOR TREATMENT WITH SEVERAL INTERMITTENT ISONIAZID-CONTAINING REGIMENS
ELLARD, GA
GAMMON, PT
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 4 (01) : 5 - 14
[7] PHARMACOGENETICS
EVANS, DAP
[J]. AMERICAN JOURNAL OF MEDICINE, 1963, 34 (05) : 639 - +
[8] EVANS DAP, 1960, BRIT MED J, V2, P458
[9] EVANS DAP, 1986, ETHNIC DIFFERENCES R, P209
[10] GELBER R, 1971, CLIN PHARMACOL THER, V12, P225